Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00462644 · ClinicalTrials.gov registry record · NA
Evaluation of Etomidate on Adrenal Function in Trauma Patients
A NA study, sponsored by University of Tennessee.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT00462644: Completed NA study, sponsored by University of Tennessee.
NCT00462644 is a NA study that has completed, run by University of Tennessee. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00462644, a NA study, has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Trauma patients are at increased risk for adrenal function insufficiency. A commonly used agent for rapid sequence intubation (RSI) is known to decrease adrenal function. We want to determine the incidence of adrenocortical insufficiency and its significance during the first 24 hours of resuscitation following RSI in trauma patients.
Interventions
- DRUG RSI sedation with etomidate/succinylcholine
- DRUG RSI sedation with fentanyl/midazolam/succinylcholine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-02 |
| Est. Completion | 2006-09 |
| Phase | NA |
What the finished NCT00462644 record still lists
NCT00462644 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which RSI sedation with etomidate/succinylcholine is the first listed.
NCT00462644 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00462644 about?
NCT00462644 is a clinical study titled "Evaluation of Etomidate on Adrenal Function in Trauma Patients". Trauma patients are at increased risk for adrenal function insufficiency. A commonly used agent for rapid sequence intubation (RSI) is known to decrease adrenal function. We want to determine the incidence of adrenocortical insufficiency and its significance during the first 24 hours of resuscitatio...
What is the current status of trial NCT00462644?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2006-02. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00462644?
The interventions under investigation include: RSI sedation with etomidate/succinylcholine (DRUG), RSI sedation with fentanyl/midazolam/succinylcholine (DRUG).
Who is sponsoring clinical trial NCT00462644?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00462644's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia